• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Bullfrog AI Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    12/27/24 4:05:20 PM ET
    $BFRG
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $BFRG alert in real time by email
    false 0001829247 0001829247 2024-12-27 2024-12-27 0001829247 BFRG:CommonStockParValue0.00001Member 2024-12-27 2024-12-27 0001829247 BFRG:TradeableWarrantsMember 2024-12-27 2024-12-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): December 27, 2024

     

    BULLFROG AI HOLDINGS, INC.

    (Exact name of Registrant as specified in its charter)

     

    Nevada   001-41600   84-4786155
    (State or other jurisdiction
    of incorporation)
     

    (Commission

    File Number)

      (I.R.S. Employer
    Identification No.)

     

    325 Ellington Blvd, Unit 317
    Gaithersburg, MD 20878
    (Address of principal executive offices) (Zip Code)

     

    Registrant’s telephone number, including area code: (240) 658-6710

     

    Not Applicable
    (Former name or former address, if changed since last report)

     

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
      
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
      
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
      
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered

    Common Stock, par value $0.00001 per share

      BFRG  

    The Nasdaq Stock Market LLC

    (The Nasdaq Capital Market)

    Tradeable Warrants   BFRGW  

    The Nasdaq Stock Market LLC

    (The Nasdaq Capital Market)

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     
     

     

    Item 8.01 Other Events.

     

    On December 27, 2024, Bullfrog AI Holdings, Inc. issued a letter to its stockholders. A copy of the letter to stockholders is attached hereto and incorporated herein by reference in its entirety as Exhibit 99.1.

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d)  

    Exhibits.

         
        The following exhibit is being furnished herein:
         
    99.1   Press release, dated December 27, 2024
    104   Cover Page Interactive Data File (formatted as Inline XBRL)

     

     
     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: December 27, 2024 Bullfrog AI Holdings, Inc.
         
      By: /s/ Vininder Singh
      Name:  Vininder Singh
      Title:  Chief Executive Officer

     

     

    Get the next $BFRG alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BFRG

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BFRG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Singh Vininder sold $43,625 worth of shares (29,002 units at $1.50), decreasing direct ownership by 1% to 2,292,446 units (SEC Form 4)

      4 - BullFrog AI Holdings, Inc. (0001829247) (Issuer)

      7/8/25 5:55:24 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chief Executive Officer Singh Vininder sold $32,911 worth of shares (20,998 units at $1.57), decreasing direct ownership by 0.90% to 2,321,448 units (SEC Form 4)

      4 - BullFrog AI Holdings, Inc. (0001829247) (Issuer)

      7/3/25 4:15:14 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chief Executive Officer Singh Vininder sold $7,686 worth of shares (5,895 units at $1.30), decreasing direct ownership by 0.25% to 2,342,446 units (SEC Form 4)

      4 - BullFrog AI Holdings, Inc. (0001829247) (Issuer)

      4/4/25 4:18:50 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $BFRG
    SEC Filings

    See more
    • Bullfrog AI Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer)

      6/12/25 4:35:06 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 10-Q filed by Bullfrog AI Holdings Inc.

      10-Q - BullFrog AI Holdings, Inc. (0001829247) (Filer)

      5/13/25 4:10:43 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Bullfrog AI Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer)

      4/28/25 9:00:30 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $BFRG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • BullFrog AI Unveils BullFrog Data Networks™ Solutions Library, Expanding Scalable AI-Powered Biomedical Insight Platform to Large Enterprises

      New Data Networks Solutions Library includes native deployment support across Google Cloud Platform, Microsoft Azure, and Amazon Web Services Built for scale, security, and domain expertise, the enterprise-wide solution is poised to transform drug development for the world's largest biopharma organizations GAITHERSBURG, Md., July 10, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence ("AI") and machine learning to enable the successful development of pharmaceuticals and biologics, today unveiled its new BullFrog Data Networks™ Solutions Library, an enterpri

      7/10/25 8:00:00 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BullFrog AI's Dr. Juan Felipe Beltrán to Highlight Advanced AI Strategies in Bioinformatics at XTalks Webinar

      GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that Dr. Juan Felipe Beltrán, Director of AI, Machine Learning, and Innovation, will be the featured speaker at the upcoming XTalks webinar: AI in Bioinformatics: Overcoming Pitfalls in Statistical, ML and Generative AI Approaches. Vin Singh, Founder and CEO of BullFrog AI, commented, "Dr. Beltrán's featured participation in the XTalks webinar not only highlights our

      6/20/25 8:00:00 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BullFrog AI Announces Strategic Collaboration with Sygnature Discovery to Introduce BullFrog Data Networks™ to Global Biopharma Clients

      GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced a strategic collaboration with Sygnature Discovery, a leading UK-based contract research organization (CRO) specializing in drug discovery. Through this collaboration, Sygnature will introduce BullFrog Data Networks™—BullFrog's proprietary AI-driven data insights platform powered by the bfLEAP™ engine—to Sygnature's global client base of relevant biopharma companies.

      6/12/25 8:00:00 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $BFRG
    Financials

    Live finance-specific insights

    See more
    • BullFrog AI and GreenPower Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

      ORLANDO, FL / ACCESSWIRE / April 26, 2024 / RedChip Companies will air interviews with BullFrog AI Holdings, Inc. (NASDAQ:BFRG) and GreenPower Motor Company Inc. (NASDAQ:GP) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, April 27, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:BullFrog AI: https://www.redchip.com/assets/access/bfrg_accessGreenPower: https://www.redchip.com/assets/access/gp_accessIn an exclusive interview, Vin Singh, CEO of BullFrog AI, appears on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV to provide a corporate u

      4/26/24 9:00:00 AM ET
      $BFRG
      $GP
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Construction/Ag Equipment/Trucks
      Consumer Discretionary
    • ASP Isotopes and Bullfrog AI Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

      ORLANDO, FL / ACCESSWIRE / October 27, 2023 / RedChip Companies will air interviews with ASP Isotopes Inc. (NASDAQ:ASPI) and BullFrog AI Holdings, Inc. (NASDAQ:BFRG)(NASDAQ:BFRGW) on The RedChip Small Stocks Big Money® Show, a sponsored program on Bloomberg TV, this Saturday, October 28, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:ASP Isotopes: https://www.redchip.com/assets/access/aspi_accessBullfrog AI: https://www.redchip.com/assets/access/bfrg_accessPaul Mann, CEO, of ASP Isotopes appears on the RedChip Small Stocks Big Money® Show on Bloomberg TV to provide a corporate update. ASP Isoto

      10/27/23 9:00:00 AM ET
      $ASPI
      $BFRG
      Major Chemicals
      Industrials
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • RedChip Launches 'Small Stocks, Big Money' Podcast

      New podcast series shines a spotlight on undervalued small-cap and microcap stocksORLANDO, FL / ACCESSWIRE / August 2, 2023 / RedChip Companies, a renowned international investor relations firm specializing in microcap and small-cap companies,announce the launch of its much-anticipated podcast series, "Small Stocks, Big Money."Hosted by RedChip CEO Dave Gentry and Associate Director Barrett Boone, the "Small Stocks, Big Money" podcast aims to offer a first-hand look at undiscovered small-cap and microcap stocks before they catch the attention of bigger Wall Street players. The series features in-depth interviews with executives from some of the top names in smaller cap stocks, providing list

      8/2/23 12:45:00 PM ET
      $BFRG
      $LTRN
      $RVPH
      $STSS
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Medical/Dental Instruments
      Pharmaceuticals and Biotechnology

    $BFRG
    Leadership Updates

    Live Leadership Updates

    See more
    • BullFrog AI Issues Letter to Stockholders

      GAITHERSBURG, Md., Dec. 27, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, issued a letter to stockholders from its CEO Vin Singh. Dear Fellow Stockholders, As the year comes to a close, I want to extend my deepest gratitude for your unwavering support and belief in our mission to revolutionize drug development. Your commitment fuels our drive to innovate and achieve transformational milestones. In thinking back on this past year, it is evident that 2024 wa

      12/27/24 8:00:00 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BullFrog AI Announces Appointment of Chief Financial Officer

      GAITHERSBURG, Md., Dec. 17, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the appointment of Josh Blacher as its Chief Financial Officer (CFO), effective immediately. This appointment comes in the wake of the untimely passing of Dane Saglio, BullFrog AI's former CFO, who recently lost his battle with cancer. "Dane's contributions to BullFrog AI were immeasurable. Beyond his exceptional expertise and dedication, Dane was a trusted advisor and

      12/17/24 4:30:00 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni

      GAITHERSBURG, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) -- BullFrog AI, Inc. (NASDAQ:BFRG, BFRGW))) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the appointment of John Baldoni, Ph.D., to its Scientific Advisory Board. Dr. Baldoni brings over four decades of experience in the pharmaceutical industry, including leadership roles in scientific research and technology-driven drug discovery. Dr. Baldoni's career includes 29 years in R&D at GSK, where he served as Senior Vice President of Platform and Technology Sciences, lea

      10/15/24 7:30:00 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care